GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nykode Therapeutics AS (OTCPK:VACBF) » Definitions » Total Equity

VACBF (Nykode Therapeutics AS) Total Equity : $136.21 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Nykode Therapeutics AS Total Equity?

Nykode Therapeutics AS's total equity for the quarter that ended in Dec. 2024 was $136.21 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Nykode Therapeutics AS Total Equity Historical Data

The historical data trend for Nykode Therapeutics AS's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nykode Therapeutics AS Total Equity Chart

Nykode Therapeutics AS Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Equity
Get a 7-Day Free Trial 178.85 194.06 157.02 171.26 136.21

Nykode Therapeutics AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 171.26 158.72 152.08 142.64 136.21

Nykode Therapeutics AS Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Nykode Therapeutics AS's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=153.481-17.267
=136.21

Nykode Therapeutics AS's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=153.481-17.267
=136.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nykode Therapeutics AS Total Equity Related Terms

Thank you for viewing the detailed overview of Nykode Therapeutics AS's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Nykode Therapeutics AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nykode Therapeutics AS (OTCPK:VACBF) » Definitions » Total Equity
Comparable Companies
OSL:TRMED OSL:AZT OSL:HBC OSL:ZLNA OSL:LYTIX OSL:EXTX OSL:ONCIN OSL:ABS OSL:SOFTX OSL:BGBIO VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
NYKD:Norway 5VB:Germany
Address
Gaustadalleen 21, Oslo Research Park, Oslo, NOR, 0349
Website
https://www.nykode.com
Nykode Therapeutics AS is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immunotherapies. The company is developing individualized cancer neoantigen vaccines and is using the Vaccibody technology to generate therapeutics to treat cancers with a high unmet medical need.